RSLS logo

ReShape Lifesciences (RSLS) Gross Profit

Annual Gross Profit

$5.55 M
-$1.25 M-18.44%

December 31, 2023


Summary


Performance

RSLS Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRSLSprofitabilitymetrics:

Quarterly Gross Profit

$1.44 M
+$305.00 K+26.90%

September 30, 2024


Summary


Performance

RSLS Quarterly Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRSLSprofitabilitymetrics:

TTM Gross Profit

$5.58 M
+$151.00 K+2.78%

September 30, 2024


Summary


Performance

RSLS TTM Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRSLSprofitabilitymetrics:

Gross Profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

RSLS Gross Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-18.4%+11.7%+5.2%
3 y3 years-11.4%-32.6%-32.1%
5 y5 years+1152.4%-36.9%-17.2%

RSLS Gross Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-33.5%at low-31.5%+26.9%-33.2%+5.2%
5 y5-year-40.4%at low-37.0%+71.9%-40.0%+5.2%
alltimeall time-40.4%-100.0%-49.6%+9693.3%-40.0%-100.0%

ReShape Lifesciences Gross Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.44 M(+26.9%)
$5.58 M(+2.8%)
Jun 2024
-
$1.13 M(-2.7%)
$5.43 M(-1.1%)
Mar 2024
-
$1.17 M(-36.8%)
$5.49 M(-1.1%)
Dec 2023
$5.55 M(-18.4%)
$1.84 M(+43.0%)
$5.55 M(+4.6%)
Sep 2023
-
$1.29 M(+7.9%)
$5.31 M(-13.3%)
Jun 2023
-
$1.19 M(-2.5%)
$6.12 M(-10.1%)
Mar 2023
-
$1.22 M(-23.5%)
$6.81 M(+0.1%)
Dec 2022
$6.80 M(-18.5%)
$1.60 M(-23.8%)
$6.80 M(-2.5%)
Sep 2022
-
$2.10 M(+11.6%)
$6.98 M(-0.5%)
Jun 2022
-
$1.88 M(+54.6%)
$7.01 M(-3.7%)
Mar 2022
-
$1.22 M(-31.4%)
$7.28 M(-12.8%)
Dec 2021
$8.35 M(+33.3%)
$1.78 M(-16.8%)
$8.35 M(+1.6%)
Sep 2021
-
$2.13 M(-0.8%)
$8.21 M(-1.7%)
Jun 2021
-
$2.15 M(-5.7%)
$8.36 M(+18.7%)
Mar 2021
-
$2.28 M(+39.2%)
$7.04 M(+12.5%)
Dec 2020
$6.26 M(-32.7%)
$1.64 M(-28.1%)
$6.26 M(-7.0%)
Sep 2020
-
$2.28 M(+172.5%)
$6.74 M(+2.7%)
Jun 2020
-
$837.00 K(-44.3%)
$6.56 M(-23.5%)
Mar 2020
-
$1.50 M(-28.9%)
$8.58 M(-7.8%)
Dec 2019
$9.30 M(+2000.5%)
$2.12 M(+0.6%)
$9.30 M(+23.0%)
Sep 2019
-
$2.10 M(-26.4%)
$7.56 M(+38.9%)
Jun 2019
-
$2.86 M(+28.1%)
$5.45 M(+109.8%)
Mar 2019
-
$2.23 M(+499.7%)
$2.60 M(+485.8%)
Dec 2018
$443.00 K(+87.8%)
$372.00 K(-2580.0%)
$443.00 K(+294.5%)
Sep 2018
-
-$15.00 K(-314.3%)
$112.30 K(-58.8%)
Jun 2018
-
$7000.00(-91.1%)
$272.80 K(-10.4%)
Mar 2018
-
$79.00 K(+91.3%)
$304.40 K(+29.0%)
Dec 2017
$235.90 K(-33.6%)
$41.30 K(-71.6%)
$235.90 K(-4.5%)
Sep 2017
-
$145.50 K(+276.9%)
$247.10 K(-1.8%)
Jun 2017
-
$38.60 K(+267.6%)
$251.70 K(-24.6%)
Mar 2017
-
$10.50 K(-80.0%)
$333.80 K(-6.0%)
Dec 2016
$355.20 K
$52.50 K(-65.0%)
$355.20 K(-6.7%)
DateAnnualQuarterlyTTM
Sep 2016
-
$150.10 K(+24.4%)
$380.80 K(+40.3%)
Jun 2016
-
$120.70 K(+278.4%)
$271.40 K(+36.5%)
Mar 2016
-
$31.90 K(-59.2%)
$198.90 K(+19.1%)
Dec 2015
$167.00 K(>+9900.0%)
$78.10 K(+91.9%)
$167.00 K(+87.9%)
Sep 2015
-
$40.70 K(-15.6%)
$88.90 K(+84.4%)
Jun 2015
-
$48.20 K(>+9900.0%)
$48.20 K(>+9900.0%)
Mar 2015
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2014
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2014
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2014
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2014
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2013
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2013
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2013
-
$0.00(0.0%)
$42.40 K(-47.0%)
Dec 2012
$80.00 K(>+9900.0%)
$0.00(0.0%)
$80.00 K(0.0%)
Sep 2012
-
$0.00(-100.0%)
$80.00 K(0.0%)
Jun 2012
-
$42.40 K(+12.8%)
$80.00 K(+112.8%)
Mar 2012
-
$37.60 K(>+9900.0%)
$37.60 K(>+9900.0%)
Dec 2011
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2011
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2011
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2010
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2010
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2010
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2010
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2009
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2009
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2009
-
$0.00
$0.00
Dec 2008
$0.00
-
-

FAQ

  • What is ReShape Lifesciences annual gross profit?
  • What is the all time high annual gross profit for ReShape Lifesciences?
  • What is ReShape Lifesciences annual gross profit year-on-year change?
  • What is ReShape Lifesciences quarterly gross profit?
  • What is the all time high quarterly gross profit for ReShape Lifesciences?
  • What is ReShape Lifesciences quarterly gross profit year-on-year change?
  • What is ReShape Lifesciences TTM gross profit?
  • What is the all time high TTM gross profit for ReShape Lifesciences?
  • What is ReShape Lifesciences TTM gross profit year-on-year change?

What is ReShape Lifesciences annual gross profit?

The current annual gross profit of RSLS is $5.55 M

What is the all time high annual gross profit for ReShape Lifesciences?

ReShape Lifesciences all-time high annual gross profit is $9.30 M

What is ReShape Lifesciences annual gross profit year-on-year change?

Over the past year, RSLS annual gross profit has changed by -$1.25 M (-18.44%)

What is ReShape Lifesciences quarterly gross profit?

The current quarterly gross profit of RSLS is $1.44 M

What is the all time high quarterly gross profit for ReShape Lifesciences?

ReShape Lifesciences all-time high quarterly gross profit is $2.86 M

What is ReShape Lifesciences quarterly gross profit year-on-year change?

Over the past year, RSLS quarterly gross profit has changed by +$151.00 K (+11.72%)

What is ReShape Lifesciences TTM gross profit?

The current TTM gross profit of RSLS is $5.58 M

What is the all time high TTM gross profit for ReShape Lifesciences?

ReShape Lifesciences all-time high TTM gross profit is $9.30 M

What is ReShape Lifesciences TTM gross profit year-on-year change?

Over the past year, RSLS TTM gross profit has changed by +$274.00 K (+5.16%)